Kodiak Sciences Inc. $317 Million Follow-On Offering
Davis Polk advised the joint bookrunning managers and representatives of the several underwriters in connection with a $317.4 million public offering of common stock by Kodiak Sciences Inc. The common stock is listed on the Nasdaq Global Market under the symbol “KOD.”
Kodiak is a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases.
The Davis Polk corporate team included partners Bruce K. Dallas and Emily Roberts and associates Dongbiao Shen and Joseph G. Marano. Partner Rachel D. Kleinberg and associate Adam R. Brownstone provided tax advice. Counsel Bonnie Chen and associate Jennifer Leather provided intellectual property and technology advice. Members of the Davis Polk team are based in the Northern California and New York offices.